Novel disubstituted chrysene as a potent agent against colon cancer

Oncology Letters

Volumn 1, Issue 6, 2010, Pages 1033-1035

  Banik, Bimal K ^a   Basu, Manas K ^b   Becker, Fredrick F ^b  

^a UNIVERSITY OF TEXAS PAN AMERICAN   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chrysene derivative; Colon cancer cell line; In vivo test

Indexed keywords

6,12 DIAMINOCHRYSENE; CHRYSENE DERIVATIVE; NITRIC ACID; POLYCYCLIC AROMATIC COMPOUND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MODIFICATION; COLON CANCER; CONTROLLED STUDY; CROSS COUPLING REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NITRATION; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME;

EID: 77957940752     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2010.167     Document Type: Article

References (12)

1. Harvey RG: Polycyclic Aromatic Hydrocarbons, Wiley-VCH, NY, 1997.
2. Bair KW, Andrews CW, Tuttle RL, Knick VC, Cory M and McKee DD: 2-(Arylmethyl)amino-2methyl-1,3-propanediol DNA intercalators: An examination of the effects of aromatic ring variation on antitumor activity and DNA binding. J Med Chem 34: 1983-1990, 1991.
3. Malviya VK, Liu PY, Alberts DS, Surwit EA, Craig JB and Hanningan EV: Evaluation of amonafide in cervical cancer, phase II. A SWOG study. Am J Clin Oncol 15: 41-44, 1992.
4. Sami SM, Dorr RT, Solyion AM, Alberts DS and Remers WA: Amino-substituted2-[2/-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. Synthesis, anti-tumor activity and quantitative structure-activity relationship. J Med Chem 38: 983-993, 1995.
5. Fukushima T, Kawai Y, Nakayama T, Yamaguchi T, YoshidaA, Urasaki Y, Imamura S, Kamiya K, Tsutani H, Ueda T and Nakamura T: Superior cytotoxic potency of mitoxantrone in interaction with DNA: comparison with that of daunorubicin. Oncol Res 8: 95-100, 1996.
6. Denny WA, Rewcastle GW and Ganguley BC: Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of minimal DNA-intercalating agents which may not act via topoisomeraseII. J Med Chem 33: 814-819, 1990.
7. Banik BK and Becker FF: Polycylic aromatic compounds as anticancer agents: structure-activity relationships of new chrysene and pyrene derivatives. Bioorg Med Chem 9: 593, 2001.
8. Becker FF, Mukhopadhyay C, Hackfeld L, Banik I and BanikBK: Polycyclic aromatic compounds as anticancer agents: synthesis and biological evaluation of dibenzofluorene derivatives. Bioorg Med Chem 8: 2693-2699, 2000.
9. Banik I, Becker FF and Banik BK: Stereoselective synthesis of β-lactams with polyaromatic imines: entry to new and novel anticancer agents. J Med Chem 46: 12-15, 2003.
10. Samajdar S, Becker FF and Banik BK: Surface-mediated highly efficient regioselective nitration of aromatic compounds by bismuth nitrate. Tetrahedron Lett 41: 8017-8020, 2000.
11. Banik BK, Banik I and Becker FF: Indium/ammonium chloride-induced selective reduction of aromatic nitro compounds. Org Syn 81: 188, 2004.
12. Ghatak A, Becker FF and Banik BK: Samarium induced alkyl halide mediated reductive coupling of detones. Tetrahedron Lett 41: 3793-3796, 2000.